Article ; Online: The effectiveness of anti-inflammatory agents in reducing chemotherapy-induced cognitive impairment in preclinical models - A systematic review.
Neuroscience and biobehavioral reviews
2023 Volume 148, Page(s) 105120
Abstract: Chemotherapy-induced cognitive impairment (CICI) is a debilitating condition resulting from chemotherapy administration for cancer treatment. CICI is characterised by various cognitive impairments, including issues with learning, memory, and ... ...
Abstract | Chemotherapy-induced cognitive impairment (CICI) is a debilitating condition resulting from chemotherapy administration for cancer treatment. CICI is characterised by various cognitive impairments, including issues with learning, memory, and concentration, impacting quality of life. Several neural mechanisms are proposed to drive CICI, including inflammation, therefore, anti-inflammatory agents could ameliorate such impairments. Research is still in the preclinical stage; however, the efficacy of anti-inflammatories to reduce CICI in animal models is unknown. Therefore, a systematic review was conducted, with searches performed in PubMed, Scopus, Embase, PsycInfo and Cochrane Library. A total of 64 studies were included, and of the 50 agents identified, 41 (82%) reduced CICI. Interestingly, while non-traditional anti-inflammatory agents and natural compounds reduced impairment, the traditional agents were unsuccessful. Such results must be taken with caution due to the heterogeneity observed in terms of methods employed. Nevertheless, preliminary evidence suggests anti-inflammatory agents could be beneficial for treating CICI, although it may be critical to think beyond the use of traditional anti-inflammatories when considering which specific compounds to prioritise in development. |
---|---|
MeSH term(s) | Animals ; Antineoplastic Agents/adverse effects ; Quality of Life ; Chemotherapy-Related Cognitive Impairment/drug therapy ; Cognitive Dysfunction/chemically induced ; Cognitive Dysfunction/drug therapy ; Anti-Inflammatory Agents/pharmacology ; Anti-Inflammatory Agents/therapeutic use |
Chemical Substances | Antineoplastic Agents ; Anti-Inflammatory Agents |
Language | English |
Publishing date | 2023-03-09 |
Publishing country | United States |
Document type | Systematic Review ; Journal Article ; Review ; Research Support, Non-U.S. Gov't |
ZDB-ID | 282464-4 |
ISSN | 1873-7528 ; 0149-7634 |
ISSN (online) | 1873-7528 |
ISSN | 0149-7634 |
DOI | 10.1016/j.neubiorev.2023.105120 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Zs.A 1371: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (1.OG) ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.